BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22353332)

  • 1. Telmisartan-induced lithium intoxication in a patient with schizoaffective disorder.
    Ma CC; Shiah IS; Chang SW; Kao YC; Lee WK
    Psychiatry Clin Neurosci; 2012 Mar; 66(2):165-6. PubMed ID: 22353332
    [No Abstract]   [Full Text] [Related]  

  • 2. Lithium intoxication after valsartan treatment.
    Su YP; Chang CJ; Hwang TJ
    Psychiatry Clin Neurosci; 2007 Apr; 61(2):204. PubMed ID: 17362443
    [No Abstract]   [Full Text] [Related]  

  • 3. Telmisartan-induced lichen planus eruption manifested on vitiliginous skin.
    Chan WP; Mackey VT; Sun DK
    Cutis; 2017 Jan; 99(1):E16-E19. PubMed ID: 28207015
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fixed combination of telmisartan and amlodipine. Lowering blood pressure with dual power].
    MMW Fortschr Med; 2010 Nov; 152(44):100-1. PubMed ID: 21158187
    [No Abstract]   [Full Text] [Related]  

  • 5. Blepharospasm and apraxia of eyelid opening in lithium intoxication.
    Micheli F; Cersósimo G; Scorticati MC; Ledesma D; Molinos J
    Clin Neuropharmacol; 1999; 22(3):176-9. PubMed ID: 10367183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy.
    Lacourcière Y; Tytus R; O'Keefe D; Lenis J; Orchard R; Martin K
    J Hum Hypertens; 2001 Nov; 15(11):763-70. PubMed ID: 11687919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy, safety and tolerability of telmisartan with losartan in Indian patients with mild to moderate hypertension: a pilot study.
    Samra SS; Dongre N; Ballary C; Desai A
    J Indian Med Assoc; 2003 May; 101(5):327-8. PubMed ID: 14575232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adjunctive effect of telmisartan in patients with hypertension uncontrolled on current antihypertensive therapy.
    Gil-Extremera B; Ma PT; Yulde J; Kalnins U; Harkin N; Williams L
    Int J Clin Pract; 2003 Dec; 57(10):861-6. PubMed ID: 14712886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension.
    Lacourcière Y; Gil-Extremera B; Mueller O; Byrne M; Williams L
    Int J Clin Pract; 2003 May; 57(4):273-9. PubMed ID: 12800457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Telmisartan and valsartan].
    Perspect Infirm; 2013; 10(5):63. PubMed ID: 24358681
    [No Abstract]   [Full Text] [Related]  

  • 12. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
    Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
    J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
    Serebruany VL; Atar D; Hanley DF
    Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients.
    Guthrie RM; Dahlöf B; Jamerson KA; Olvera R; Seeber M; Schumacher H; Oigman W
    Curr Med Res Opin; 2011 Oct; 27(10):1995-2008. PubMed ID: 21905967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythema multiforme-type drug eruption with prominent keratinocyte necrosis induced by long-term administration of telmisartan.
    Fujii M; Takahashi I; Kishiyama K; Honma M; Ishida-Yamamoto A
    J Dermatol; 2015 May; 42(5):537-9. PubMed ID: 25771951
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension.
    Nalbantgil I; Nalbantgil S; Ozerkan F; Yilmaz H; Gürgün C; Zoghi M; Aytimur M; Onder R
    Int J Clin Pract Suppl; 2004 Dec; (145):50-4. PubMed ID: 15617460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
    Oparil S; Kjeldsen SE; Hedner T; Narkiewicz K
    Blood Press; 2009; 18(1-2):4-6. PubMed ID: 19191085
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2).
    Parati G; Bilo G; Redon J;
    Hypertens Res; 2013 Apr; 36(4):322-7. PubMed ID: 23154590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of cough: a comparison of lisinopril, placebo and telmisartan, a novel angiotensin II antagonist. Telmisartan Cough Study Group.
    Lacourciére Y
    Int J Clin Pract; 1999 Mar; 53(2):99-103. PubMed ID: 10344043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.